These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21559684)

  • 1. Analysis of the C-myc promoter-binding factor zf87/pur1 in transformed and nontransformed cell-lines.
    Pyrc J; Logan T; Hall D
    Int J Oncol; 1994 Nov; 5(5):1085-91. PubMed ID: 21559684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ.
    Izzo MW; Strachan GD; Stubbs MC; Hall DJ
    J Biol Chem; 1999 Jul; 274(27):19498-506. PubMed ID: 10383467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.
    Jordan-Sciutto KL; Dragich JM; Caltagarone J; Hall DJ; Bowser R
    Biochemistry; 2000 Mar; 39(12):3206-15. PubMed ID: 10727212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ZF87/MAZ transcription factor functions as a growth suppressor in fibroblasts.
    Stubbs MC; Min I; Izzo MW; Rallapalli R; Derfoul A; Hall DJ
    Biochem Cell Biol; 2000; 78(4):477-85. PubMed ID: 11012087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter.
    Pyrc JJ; Moberg KH; Hall DJ
    Biochemistry; 1992 Apr; 31(16):4102-10. PubMed ID: 1567856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characteristics of a factor related to the c-myc/insulin promoter binding protein ZF87/Pur-1.
    Logan T; Pyrc J; Hall DJ
    Biochem Biophys Res Commun; 1993 May; 192(3):1204-9. PubMed ID: 8507192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
    Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
    Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.
    Bossone SA; Asselin C; Patel AJ; Marcu KB
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7452-6. PubMed ID: 1502157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1.
    Hall DJ
    Oncogene; 1990 Jan; 5(1):47-54. PubMed ID: 2181377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three distinct elements within the murine c-myc promoter are required for transcription.
    Moberg KH; Logan TJ; Tyndall WA; Hall DJ
    Oncogene; 1992 Mar; 7(3):411-21. PubMed ID: 1549358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAZ, a Myc-associated zinc finger protein, is essential for the ME1a1-mediated expression of the c-myc gene during neuroectodermal differentiation of P19 cells.
    Komatsu M; Li HO; Tsutsui H; Itakura K; Matsumura M; Yokoyama KK
    Oncogene; 1997 Sep; 15(10):1123-31. PubMed ID: 9294605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor and gamma-interferon repress transcription from the c-myc P2 promoter by reducing E2F binding activity.
    Carlberg AL; Moberg KH; Hall DJ
    Int J Oncol; 1999 Jul; 15(1):121-6. PubMed ID: 10375604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
    Majello B; De Luca P; Suske G; Lania L
    Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
    Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
    Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
    Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor.
    Watanabe S; Ishida S; Koike K; Arai K
    Mol Biol Cell; 1995 Jun; 6(6):627-36. PubMed ID: 7579683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.
    Thalmeier K; Synovzik H; Mertz R; Winnacker EL; Lipp M
    Genes Dev; 1989 Apr; 3(4):527-36. PubMed ID: 2721961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.